Detalle Publicación

CD69 is a direct HIF-1 alpha target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes
Autores: Labiano Almiñana, Sara; Melendez Rodriguez, F.; Palazon, A.; Teijeira Sánchez, Álvaro; Garasa, S.; Etxeberria Uriz, Iñaki; Aznar Gómez, María Ángela; Sanchez Paulete, A. R.; Azpilikueta, A.; Bolaños Mateo, Elixabet; Molina Samper, Carmen; de la Fuente, H.; Maiso Castellanos, Patricia; Sanchez Madrid, F.; de Landazuri, M. O.; Aragones, J.; Melero Bermejo, Ignacio
Título de la revista: ONCOIMMUNOLOGY
ISSN: 2162-402X
Volumen: 6
Número: 4
Páginas: e1283468
Fecha de publicación: 2017
Lugar: WOS
CD69 is an early activation marker on the surface of T lymphocytes undergoing activation by cognate antigen. We observed intense expression of CD69 on tumor-infiltrating T-lymphocytes that reside in the hypoxic tumor microenvironment and hypothesized that CD69 could be, at least partially, under the control of the transcriptional hypoxia response. In line with this, human and mouse CD3-stimulated lymphocytes cultured under hypoxia (1% O-2) showed increased expression of CD69 at the protein and mRNA level. Consistent with these findings, mouse T lymphocytes that had recently undergone hypoxia in vivo, as denoted by pimonidazole staining, were more frequently CD69(+) in the tumor and bone marrow hypoxic tissue compartments. We found evidence for HIF-1 involvement both when using T-lymphocytes from inducible HIF-1(-/-) mice and when observing tumor-infiltrating T-lymphocytes in mice whose T cells are HIF-1(-/-). Direct pro-transcriptional activity of HIF-1 on a newly identified hypoxia response element (HRE) found in the human CD69 locus was demonstrated by ChIP experiments. These results uncover a connection between the HIF-1 oxygen-sensing pathway and CD69 immunobiology.